Erratum: High-background parenchymal enhancement in the contralateral breast is an imaging biomarker for favorable prognosis in patients with triple-negative breast cancer treated with chemotherapy

Am J Transl Res. 2023 Jul 15;15(7):4970. eCollection 2023.

Abstract

[This corrects the article on p. 4422 in vol. 13, PMID: 34150024.].

Publication types

  • Published Erratum